Medical Care
Global Human Microbiome Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 01, 25
- ID: 282326
- Pages: 146
- Figures: 155
- Views: 4
In 2024, the global market size of Human Microbiome was estimated to be worth US$ 568 million and is forecast to reach approximately US$ 2207 million by 2031 with a CAGR of 21.7% during the forecast period 2025-2031.
The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that"s 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
At present, global investment concentrates in US and Europe, US takes 70% market share and Europe takes 25% market share. There are a few manufacturers in the world and the market concentration is high. The top5 (investment in Human Micobiome) companies are Vedanta, Seres Therapeutics, Second Genome, Rebiocix, ActoGeniX. The five companies occupy about 70% of the market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Microbiome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Microbiome.
The Human Microbiome market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Microbiome market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Microbiome companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
Segment by Type
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Others
Segment by Application
Treatment
Diagnosis
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Human Microbiome in global and regional level.
Chapter 3: Detailed analysis of Human Microbiome company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Microbiome revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that"s 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
At present, global investment concentrates in US and Europe, US takes 70% market share and Europe takes 25% market share. There are a few manufacturers in the world and the market concentration is high. The top5 (investment in Human Micobiome) companies are Vedanta, Seres Therapeutics, Second Genome, Rebiocix, ActoGeniX. The five companies occupy about 70% of the market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Microbiome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Microbiome.
The Human Microbiome market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Microbiome market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Microbiome companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
Segment by Type
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Others
Segment by Application
Treatment
Diagnosis
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Human Microbiome in global and regional level.
Chapter 3: Detailed analysis of Human Microbiome company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Microbiome revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Human Microbiome Product Introduction
1.2 Market by Type
1.2.1 Global Human Microbiome Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Gastrointestinal Tract Human Micobiome
1.2.3 Urogenital Tract Human Micobiome
1.2.4 Others
1.3 Market by Application
1.3.1 Global Human Microbiome Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Treatment
1.3.3 Diagnosis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human Microbiome Market Size Estimates and Forecasts
2.2 Human Microbiome Market Size by Region: 2024 Versus 2031
2.2.1 Global Human Microbiome Revenue by Region: 2020-2025
2.2.2 Global Human Microbiome Revenue Forecast by Region (2026-2031)
2.2.3 Global Human Microbiome Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Human Microbiome Revenue by Type (2020-2031)
3.1.2 Global Human Microbiome Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Human Microbiome Revenue by Application (2020-2031)
3.2.2 Global Human Microbiome Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Gastrointestinal Tract Human Micobiome of Human Microbiome Revenue Market Share by Application
3.3.2 Urogenital Tract Human Micobiome of Human Microbiome Revenue Market Share by Application
3.3.3 Others of Human Microbiome Revenue Market Share by Application
4 Global Human Microbiome by Company
4.1 Global Human Microbiome Revenue by Company (2020-2025)
4.2 Global Human Microbiome Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Human Microbiome Companies around the World: Ranking by Revenue
4.3.2 Global Human Microbiome Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Human Microbiome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Human Microbiome Companies Headquarters & Product Type
4.4.1 Global Human Microbiome Companies Headquarters
4.4.2 Date of International Companies Enter into Human Microbiome Market
4.4.3 Global Human Microbiome Companies Product & Service
4.4.4 Gastrointestinal Tract Human Micobiome Revenue Market Share of Human Microbiome by Company
4.4.5 Urogenital Tract Human Micobiome Revenue Market Share of Human Microbiome by Company
4.4.6 Others Revenue Market Share of Human Microbiome by Company
4.5 Global Human Microbiome Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Vedanta
5.1.1 Vedanta Corporation Information
5.1.2 Vedanta Description, Business Overview
5.1.3 Vedanta Human Microbiome Products Offered
5.1.4 Vedanta Human Microbiome Revenue and Gross Margin (2020-2025)
5.1.5 Vedanta Human Microbiome Revenue by Product in 2024
5.1.6 Vedanta Human Microbiome Revenue by Application in 2024
5.1.7 Vedanta Human Microbiome Revenue by Geographic Area in 2024
5.1.8 Vedanta Recent Developments
5.2 Seres Therapeutics
5.2.1 Seres Therapeutics Corporation Information
5.2.2 Seres Therapeutics Description, Business Overview
5.2.3 Seres Therapeutics Human Microbiome Products Offered
5.2.4 Seres Therapeutics Human Microbiome Revenue and Gross Margin (2020-2025)
5.2.5 Seres Therapeutics Human Microbiome Revenue by Product in 2024
5.2.6 Seres Therapeutics Human Microbiome Revenue by Application in 2024
5.2.7 Seres Therapeutics Human Microbiome Revenue by Geographic Area in 2024
5.2.8 Seres Therapeutics Recent Developments
5.3 Second Genome
5.3.1 Second Genome Corporation Information
5.3.2 Second Genome Description, Business Overview
5.3.3 Second Genome Human Microbiome Products Offered
5.3.4 Second Genome Human Microbiome Revenue and Gross Margin (2020-2025)
5.3.5 Second Genome Human Microbiome Revenue by Product in 2024
5.3.6 Second Genome Human Microbiome Revenue by Application in 2024
5.3.7 Second Genome Human Microbiome Revenue by Geographic Area in 2024
5.3.8 Second Genome Recent Developments
5.4 Rebiotix
5.4.1 Rebiotix Corporation Information
5.4.2 Rebiotix Description, Business Overview
5.4.3 Rebiotix Human Microbiome Products Offered
5.4.4 Rebiotix Human Microbiome Revenue and Gross Margin (2020-2025)
5.4.5 Rebiotix Human Microbiome Revenue by Product in 2024
5.4.6 Rebiotix Human Microbiome Revenue by Application in 2024
5.4.7 Rebiotix Human Microbiome Revenue by Geographic Area in 2024
5.4.8 Rebiotix Recent Developments
5.5 ActoGeniX
5.5.1 ActoGeniX Corporation Information
5.5.2 ActoGeniX Description, Business Overview
5.5.3 ActoGeniX Human Microbiome Products Offered
5.5.4 ActoGeniX Human Microbiome Revenue and Gross Margin (2020-2025)
5.5.5 ActoGeniX Human Microbiome Revenue by Product in 2024
5.5.6 ActoGeniX Human Microbiome Revenue by Application in 2024
5.5.7 ActoGeniX Human Microbiome Revenue by Geographic Area in 2024
5.5.8 ActoGeniX Recent Developments
5.6 Enterome BioScience
5.6.1 Enterome BioScience Corporation Information
5.6.2 Enterome BioScience Description, Business Overview
5.6.3 Enterome BioScience Human Microbiome Products Offered
5.6.4 Enterome BioScience Human Microbiome Revenue and Gross Margin (2020-2025)
5.6.5 Enterome BioScience Human Microbiome Revenue by Product in 2024
5.6.6 Enterome BioScience Human Microbiome Revenue by Application in 2024
5.6.7 Enterome BioScience Human Microbiome Revenue by Geographic Area in 2024
5.6.8 Enterome BioScience Recent Developments
5.7 AvidBiotics
5.7.1 AvidBiotics Corporation Information
5.7.2 AvidBiotics Description, Business Overview
5.7.3 AvidBiotics Human Microbiome Products Offered
5.7.4 AvidBiotics Human Microbiome Revenue and Gross Margin (2020-2025)
5.7.5 AvidBiotics Human Microbiome Revenue by Product in 2024
5.7.6 AvidBiotics Human Microbiome Revenue by Application in 2024
5.7.7 AvidBiotics Human Microbiome Revenue by Geographic Area in 2024
5.7.8 AvidBiotics Recent Developments
5.8 4D Pharma Research Ltd
5.8.1 4D Pharma Research Ltd Corporation Information
5.8.2 4D Pharma Research Ltd Description, Business Overview
5.8.3 4D Pharma Research Ltd Human Microbiome Products Offered
5.8.4 4D Pharma Research Ltd Human Microbiome Revenue and Gross Margin (2020-2025)
5.8.5 4D Pharma Research Ltd Human Microbiome Revenue by Product in 2024
5.8.6 4D Pharma Research Ltd Human Microbiome Revenue by Application in 2024
5.8.7 4D Pharma Research Ltd Human Microbiome Revenue by Geographic Area in 2024
5.8.8 4D Pharma Research Ltd Recent Developments
5.9 Enterologics
5.9.1 Enterologics Corporation Information
5.9.2 Enterologics Description, Business Overview
5.9.3 Enterologics Human Microbiome Products Offered
5.9.4 Enterologics Human Microbiome Revenue and Gross Margin (2020-2025)
5.9.5 Enterologics Human Microbiome Revenue by Product in 2024
5.9.6 Enterologics Human Microbiome Revenue by Application in 2024
5.9.7 Enterologics Human Microbiome Revenue by Geographic Area in 2024
5.9.8 Enterologics Recent Developments
5.10 Metabogen
5.10.1 Metabogen Corporation Information
5.10.2 Metabogen Description, Business Overview
5.10.3 Metabogen Human Microbiome Products Offered
5.10.4 Metabogen Human Microbiome Revenue and Gross Margin (2020-2025)
5.10.5 Metabogen Human Microbiome Revenue by Product in 2024
5.10.6 Metabogen Human Microbiome Revenue by Application in 2024
5.10.7 Metabogen Human Microbiome Revenue by Geographic Area in 2024
5.10.8 Metabogen Recent Developments
5.11 Metabiomics
5.11.1 Metabiomics Corporation Information
5.11.2 Metabiomics Description, Business Overview
5.11.3 Metabiomics Human Microbiome Products Offered
5.11.4 Metabiomics Human Microbiome Revenue and Gross Margin (2020-2025)
5.11.5 Metabiomics Human Microbiome Revenue by Product in 2024
5.11.6 Metabiomics Human Microbiome Revenue by Application in 2024
5.11.7 Metabiomics Human Microbiome Revenue by Geographic Area in 2024
5.11.8 Metabiomics Recent Developments
5.12 Ritter Pharmaceuticals
5.12.1 Ritter Pharmaceuticals Corporation Information
5.12.2 Ritter Pharmaceuticals Description, Business Overview
5.12.3 Ritter Pharmaceuticals Human Microbiome Products Offered
5.12.4 Ritter Pharmaceuticals Human Microbiome Revenue and Gross Margin (2020-2025)
5.12.5 Ritter Pharmaceuticals Human Microbiome Revenue by Product in 2024
5.12.6 Ritter Pharmaceuticals Human Microbiome Revenue by Application in 2024
5.12.7 Ritter Pharmaceuticals Human Microbiome Revenue by Geographic Area in 2024
5.12.8 Ritter Pharmaceuticals Recent Developments
5.13 Osel
5.13.1 Osel Corporation Information
5.13.2 Osel Description, Business Overview
5.13.3 Osel Human Microbiome Products Offered
5.13.4 Osel Human Microbiome Revenue and Gross Margin (2020-2025)
5.13.5 Osel Human Microbiome Revenue by Product in 2024
5.13.6 Osel Human Microbiome Revenue by Application in 2024
5.13.7 Osel Human Microbiome Revenue by Geographic Area in 2024
5.13.8 Osel Recent Developments
5.14 Symberix
5.14.1 Symberix Corporation Information
5.14.2 Symberix Description, Business Overview
5.14.3 Symberix Human Microbiome Products Offered
5.14.4 Symberix Human Microbiome Revenue and Gross Margin (2020-2025)
5.14.5 Symberix Human Microbiome Revenue by Product in 2024
5.14.6 Symberix Human Microbiome Revenue by Application in 2024
5.14.7 Symberix Human Microbiome Revenue by Geographic Area in 2024
5.14.8 Symberix Recent Developments
5.15 Miomics
5.15.1 Miomics Corporation Information
5.15.2 Miomics Description, Business Overview
5.15.3 Miomics Human Microbiome Products Offered
5.15.4 Miomics Human Microbiome Revenue and Gross Margin (2020-2025)
5.15.5 Miomics Human Microbiome Revenue by Product in 2024
5.15.6 Miomics Human Microbiome Revenue by Application in 2024
5.15.7 Miomics Human Microbiome Revenue by Geographic Area in 2024
5.15.8 Miomics Recent Developments
5.16 Symbiotix Biotherapies
5.16.1 Symbiotix Biotherapies Corporation Information
5.16.2 Symbiotix Biotherapies Description, Business Overview
5.16.3 Symbiotix Biotherapies Human Microbiome Products Offered
5.16.4 Symbiotix Biotherapies Human Microbiome Revenue and Gross Margin (2020-2025)
5.16.5 Symbiotix Biotherapies Human Microbiome Revenue by Product in 2024
5.16.6 Symbiotix Biotherapies Human Microbiome Revenue by Application in 2024
5.16.7 Symbiotix Biotherapies Human Microbiome Revenue by Geographic Area in 2024
5.16.8 Symbiotix Biotherapies Recent Developments
5.17 MicroBiome Therapeutics LLC
5.17.1 MicroBiome Therapeutics LLC Corporation Information
5.17.2 MicroBiome Therapeutics LLC Description, Business Overview
5.17.3 MicroBiome Therapeutics LLC Human Microbiome Products Offered
5.17.4 MicroBiome Therapeutics LLC Human Microbiome Revenue and Gross Margin (2020-2025)
5.17.5 MicroBiome Therapeutics LLC Human Microbiome Revenue by Product in 2024
5.17.6 MicroBiome Therapeutics LLC Human Microbiome Revenue by Application in 2024
5.17.7 MicroBiome Therapeutics LLC Human Microbiome Revenue by Geographic Area in 2024
5.17.8 MicroBiome Therapeutics LLC Recent Developments
6 North America
6.1 North America Human Microbiome Market Size YoY Growth 2020-2031
6.2 North America Human Microbiome Market Facts & Figures by Country (2020-2031)
6.3 North America Human Microbiome Revenue by Type (2020-2025)
6.4 North America Human Microbiome Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Human Microbiome Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Human Microbiome Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Human Microbiome Revenue by Type (2020-2025)
7.4 Asia-Pacific Human Microbiome Revenue by Application (2020-2025)
8 Europe
8.1 Europe Human Microbiome Market Size YoY Growth 2020-2031
8.2 Europe Human Microbiome Market Facts & Figures by Country (2020-2031)
8.3 Europe Human Microbiome Revenue by Type (2020-2025)
8.4 Europe Human Microbiome Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Human Microbiome Market Size YoY Growth 2020-2031
9.2 Latin America Human Microbiome Market Facts & Figures by Country (2020-2031)
9.3 Latin America Human Microbiome Revenue by Type (2020-2025)
9.4 Latin America Human Microbiome Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Human Microbiome Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Human Microbiome Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Human Microbiome Revenue by Type (2020-2025)
10.4 Middle East and Africa Human Microbiome Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Human Microbiome Supply Chain Analysis
11.2 Human Microbiome Key Raw Materials and Upstream Suppliers
11.3 Human Microbiome Clients Analysis
11.4 Human Microbiome Sales Channel and Sales Model Analysis
11.4.1 Human Microbiome Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Human Microbiome Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Human Microbiome Distributors
12 Human Microbiome Market Dynamics
12.1 Human Microbiome Industry Trends
12.2 Human Microbiome Market Drivers
12.3 Human Microbiome Market Challenges
12.4 Human Microbiome Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Human Microbiome Product Introduction
1.2 Market by Type
1.2.1 Global Human Microbiome Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Gastrointestinal Tract Human Micobiome
1.2.3 Urogenital Tract Human Micobiome
1.2.4 Others
1.3 Market by Application
1.3.1 Global Human Microbiome Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Treatment
1.3.3 Diagnosis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human Microbiome Market Size Estimates and Forecasts
2.2 Human Microbiome Market Size by Region: 2024 Versus 2031
2.2.1 Global Human Microbiome Revenue by Region: 2020-2025
2.2.2 Global Human Microbiome Revenue Forecast by Region (2026-2031)
2.2.3 Global Human Microbiome Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Human Microbiome Revenue by Type (2020-2031)
3.1.2 Global Human Microbiome Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Human Microbiome Revenue by Application (2020-2031)
3.2.2 Global Human Microbiome Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Gastrointestinal Tract Human Micobiome of Human Microbiome Revenue Market Share by Application
3.3.2 Urogenital Tract Human Micobiome of Human Microbiome Revenue Market Share by Application
3.3.3 Others of Human Microbiome Revenue Market Share by Application
4 Global Human Microbiome by Company
4.1 Global Human Microbiome Revenue by Company (2020-2025)
4.2 Global Human Microbiome Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Human Microbiome Companies around the World: Ranking by Revenue
4.3.2 Global Human Microbiome Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Human Microbiome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Human Microbiome Companies Headquarters & Product Type
4.4.1 Global Human Microbiome Companies Headquarters
4.4.2 Date of International Companies Enter into Human Microbiome Market
4.4.3 Global Human Microbiome Companies Product & Service
4.4.4 Gastrointestinal Tract Human Micobiome Revenue Market Share of Human Microbiome by Company
4.4.5 Urogenital Tract Human Micobiome Revenue Market Share of Human Microbiome by Company
4.4.6 Others Revenue Market Share of Human Microbiome by Company
4.5 Global Human Microbiome Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Vedanta
5.1.1 Vedanta Corporation Information
5.1.2 Vedanta Description, Business Overview
5.1.3 Vedanta Human Microbiome Products Offered
5.1.4 Vedanta Human Microbiome Revenue and Gross Margin (2020-2025)
5.1.5 Vedanta Human Microbiome Revenue by Product in 2024
5.1.6 Vedanta Human Microbiome Revenue by Application in 2024
5.1.7 Vedanta Human Microbiome Revenue by Geographic Area in 2024
5.1.8 Vedanta Recent Developments
5.2 Seres Therapeutics
5.2.1 Seres Therapeutics Corporation Information
5.2.2 Seres Therapeutics Description, Business Overview
5.2.3 Seres Therapeutics Human Microbiome Products Offered
5.2.4 Seres Therapeutics Human Microbiome Revenue and Gross Margin (2020-2025)
5.2.5 Seres Therapeutics Human Microbiome Revenue by Product in 2024
5.2.6 Seres Therapeutics Human Microbiome Revenue by Application in 2024
5.2.7 Seres Therapeutics Human Microbiome Revenue by Geographic Area in 2024
5.2.8 Seres Therapeutics Recent Developments
5.3 Second Genome
5.3.1 Second Genome Corporation Information
5.3.2 Second Genome Description, Business Overview
5.3.3 Second Genome Human Microbiome Products Offered
5.3.4 Second Genome Human Microbiome Revenue and Gross Margin (2020-2025)
5.3.5 Second Genome Human Microbiome Revenue by Product in 2024
5.3.6 Second Genome Human Microbiome Revenue by Application in 2024
5.3.7 Second Genome Human Microbiome Revenue by Geographic Area in 2024
5.3.8 Second Genome Recent Developments
5.4 Rebiotix
5.4.1 Rebiotix Corporation Information
5.4.2 Rebiotix Description, Business Overview
5.4.3 Rebiotix Human Microbiome Products Offered
5.4.4 Rebiotix Human Microbiome Revenue and Gross Margin (2020-2025)
5.4.5 Rebiotix Human Microbiome Revenue by Product in 2024
5.4.6 Rebiotix Human Microbiome Revenue by Application in 2024
5.4.7 Rebiotix Human Microbiome Revenue by Geographic Area in 2024
5.4.8 Rebiotix Recent Developments
5.5 ActoGeniX
5.5.1 ActoGeniX Corporation Information
5.5.2 ActoGeniX Description, Business Overview
5.5.3 ActoGeniX Human Microbiome Products Offered
5.5.4 ActoGeniX Human Microbiome Revenue and Gross Margin (2020-2025)
5.5.5 ActoGeniX Human Microbiome Revenue by Product in 2024
5.5.6 ActoGeniX Human Microbiome Revenue by Application in 2024
5.5.7 ActoGeniX Human Microbiome Revenue by Geographic Area in 2024
5.5.8 ActoGeniX Recent Developments
5.6 Enterome BioScience
5.6.1 Enterome BioScience Corporation Information
5.6.2 Enterome BioScience Description, Business Overview
5.6.3 Enterome BioScience Human Microbiome Products Offered
5.6.4 Enterome BioScience Human Microbiome Revenue and Gross Margin (2020-2025)
5.6.5 Enterome BioScience Human Microbiome Revenue by Product in 2024
5.6.6 Enterome BioScience Human Microbiome Revenue by Application in 2024
5.6.7 Enterome BioScience Human Microbiome Revenue by Geographic Area in 2024
5.6.8 Enterome BioScience Recent Developments
5.7 AvidBiotics
5.7.1 AvidBiotics Corporation Information
5.7.2 AvidBiotics Description, Business Overview
5.7.3 AvidBiotics Human Microbiome Products Offered
5.7.4 AvidBiotics Human Microbiome Revenue and Gross Margin (2020-2025)
5.7.5 AvidBiotics Human Microbiome Revenue by Product in 2024
5.7.6 AvidBiotics Human Microbiome Revenue by Application in 2024
5.7.7 AvidBiotics Human Microbiome Revenue by Geographic Area in 2024
5.7.8 AvidBiotics Recent Developments
5.8 4D Pharma Research Ltd
5.8.1 4D Pharma Research Ltd Corporation Information
5.8.2 4D Pharma Research Ltd Description, Business Overview
5.8.3 4D Pharma Research Ltd Human Microbiome Products Offered
5.8.4 4D Pharma Research Ltd Human Microbiome Revenue and Gross Margin (2020-2025)
5.8.5 4D Pharma Research Ltd Human Microbiome Revenue by Product in 2024
5.8.6 4D Pharma Research Ltd Human Microbiome Revenue by Application in 2024
5.8.7 4D Pharma Research Ltd Human Microbiome Revenue by Geographic Area in 2024
5.8.8 4D Pharma Research Ltd Recent Developments
5.9 Enterologics
5.9.1 Enterologics Corporation Information
5.9.2 Enterologics Description, Business Overview
5.9.3 Enterologics Human Microbiome Products Offered
5.9.4 Enterologics Human Microbiome Revenue and Gross Margin (2020-2025)
5.9.5 Enterologics Human Microbiome Revenue by Product in 2024
5.9.6 Enterologics Human Microbiome Revenue by Application in 2024
5.9.7 Enterologics Human Microbiome Revenue by Geographic Area in 2024
5.9.8 Enterologics Recent Developments
5.10 Metabogen
5.10.1 Metabogen Corporation Information
5.10.2 Metabogen Description, Business Overview
5.10.3 Metabogen Human Microbiome Products Offered
5.10.4 Metabogen Human Microbiome Revenue and Gross Margin (2020-2025)
5.10.5 Metabogen Human Microbiome Revenue by Product in 2024
5.10.6 Metabogen Human Microbiome Revenue by Application in 2024
5.10.7 Metabogen Human Microbiome Revenue by Geographic Area in 2024
5.10.8 Metabogen Recent Developments
5.11 Metabiomics
5.11.1 Metabiomics Corporation Information
5.11.2 Metabiomics Description, Business Overview
5.11.3 Metabiomics Human Microbiome Products Offered
5.11.4 Metabiomics Human Microbiome Revenue and Gross Margin (2020-2025)
5.11.5 Metabiomics Human Microbiome Revenue by Product in 2024
5.11.6 Metabiomics Human Microbiome Revenue by Application in 2024
5.11.7 Metabiomics Human Microbiome Revenue by Geographic Area in 2024
5.11.8 Metabiomics Recent Developments
5.12 Ritter Pharmaceuticals
5.12.1 Ritter Pharmaceuticals Corporation Information
5.12.2 Ritter Pharmaceuticals Description, Business Overview
5.12.3 Ritter Pharmaceuticals Human Microbiome Products Offered
5.12.4 Ritter Pharmaceuticals Human Microbiome Revenue and Gross Margin (2020-2025)
5.12.5 Ritter Pharmaceuticals Human Microbiome Revenue by Product in 2024
5.12.6 Ritter Pharmaceuticals Human Microbiome Revenue by Application in 2024
5.12.7 Ritter Pharmaceuticals Human Microbiome Revenue by Geographic Area in 2024
5.12.8 Ritter Pharmaceuticals Recent Developments
5.13 Osel
5.13.1 Osel Corporation Information
5.13.2 Osel Description, Business Overview
5.13.3 Osel Human Microbiome Products Offered
5.13.4 Osel Human Microbiome Revenue and Gross Margin (2020-2025)
5.13.5 Osel Human Microbiome Revenue by Product in 2024
5.13.6 Osel Human Microbiome Revenue by Application in 2024
5.13.7 Osel Human Microbiome Revenue by Geographic Area in 2024
5.13.8 Osel Recent Developments
5.14 Symberix
5.14.1 Symberix Corporation Information
5.14.2 Symberix Description, Business Overview
5.14.3 Symberix Human Microbiome Products Offered
5.14.4 Symberix Human Microbiome Revenue and Gross Margin (2020-2025)
5.14.5 Symberix Human Microbiome Revenue by Product in 2024
5.14.6 Symberix Human Microbiome Revenue by Application in 2024
5.14.7 Symberix Human Microbiome Revenue by Geographic Area in 2024
5.14.8 Symberix Recent Developments
5.15 Miomics
5.15.1 Miomics Corporation Information
5.15.2 Miomics Description, Business Overview
5.15.3 Miomics Human Microbiome Products Offered
5.15.4 Miomics Human Microbiome Revenue and Gross Margin (2020-2025)
5.15.5 Miomics Human Microbiome Revenue by Product in 2024
5.15.6 Miomics Human Microbiome Revenue by Application in 2024
5.15.7 Miomics Human Microbiome Revenue by Geographic Area in 2024
5.15.8 Miomics Recent Developments
5.16 Symbiotix Biotherapies
5.16.1 Symbiotix Biotherapies Corporation Information
5.16.2 Symbiotix Biotherapies Description, Business Overview
5.16.3 Symbiotix Biotherapies Human Microbiome Products Offered
5.16.4 Symbiotix Biotherapies Human Microbiome Revenue and Gross Margin (2020-2025)
5.16.5 Symbiotix Biotherapies Human Microbiome Revenue by Product in 2024
5.16.6 Symbiotix Biotherapies Human Microbiome Revenue by Application in 2024
5.16.7 Symbiotix Biotherapies Human Microbiome Revenue by Geographic Area in 2024
5.16.8 Symbiotix Biotherapies Recent Developments
5.17 MicroBiome Therapeutics LLC
5.17.1 MicroBiome Therapeutics LLC Corporation Information
5.17.2 MicroBiome Therapeutics LLC Description, Business Overview
5.17.3 MicroBiome Therapeutics LLC Human Microbiome Products Offered
5.17.4 MicroBiome Therapeutics LLC Human Microbiome Revenue and Gross Margin (2020-2025)
5.17.5 MicroBiome Therapeutics LLC Human Microbiome Revenue by Product in 2024
5.17.6 MicroBiome Therapeutics LLC Human Microbiome Revenue by Application in 2024
5.17.7 MicroBiome Therapeutics LLC Human Microbiome Revenue by Geographic Area in 2024
5.17.8 MicroBiome Therapeutics LLC Recent Developments
6 North America
6.1 North America Human Microbiome Market Size YoY Growth 2020-2031
6.2 North America Human Microbiome Market Facts & Figures by Country (2020-2031)
6.3 North America Human Microbiome Revenue by Type (2020-2025)
6.4 North America Human Microbiome Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Human Microbiome Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Human Microbiome Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Human Microbiome Revenue by Type (2020-2025)
7.4 Asia-Pacific Human Microbiome Revenue by Application (2020-2025)
8 Europe
8.1 Europe Human Microbiome Market Size YoY Growth 2020-2031
8.2 Europe Human Microbiome Market Facts & Figures by Country (2020-2031)
8.3 Europe Human Microbiome Revenue by Type (2020-2025)
8.4 Europe Human Microbiome Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Human Microbiome Market Size YoY Growth 2020-2031
9.2 Latin America Human Microbiome Market Facts & Figures by Country (2020-2031)
9.3 Latin America Human Microbiome Revenue by Type (2020-2025)
9.4 Latin America Human Microbiome Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Human Microbiome Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Human Microbiome Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Human Microbiome Revenue by Type (2020-2025)
10.4 Middle East and Africa Human Microbiome Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Human Microbiome Supply Chain Analysis
11.2 Human Microbiome Key Raw Materials and Upstream Suppliers
11.3 Human Microbiome Clients Analysis
11.4 Human Microbiome Sales Channel and Sales Model Analysis
11.4.1 Human Microbiome Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Human Microbiome Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Human Microbiome Distributors
12 Human Microbiome Market Dynamics
12.1 Human Microbiome Industry Trends
12.2 Human Microbiome Market Drivers
12.3 Human Microbiome Market Challenges
12.4 Human Microbiome Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Human Microbiome Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Human Microbiome Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Human Microbiome Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Human Microbiome Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Human Microbiome Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Human Microbiome Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Human Microbiome Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Human Microbiome Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Human Microbiome Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Human Microbiome Revenue by Company (2020-2025) & (US$ Million)
Table 11. Human Microbiome Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Human Microbiome Players by Revenue (US$ Million) in 2024
Table 13. Global Human Microbiome Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Human Microbiome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome as of 2024)
Table 15. Global Human Microbiome Companies Headquarters
Table 16. Date of International Companies Enter into Human Microbiome Market
Table 17. Global Human Microbiome Companies Product & Service
Table 18. Global Human Microbiome Mergers & Acquisitions, Expansion Plans
Table 19. Vedanta Corporation Information
Table 20. Vedanta Description and Business Overview
Table 21. Vedanta Human Microbiome Product
Table 22. Vedanta Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Vedanta Revenue Proportion of Human Microbiome by Product in 2024
Table 24. Vedanta Revenue Proportion of Human Microbiome by Application in 2024
Table 25. Vedanta Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 26. Vedanta Recent Developments
Table 27. Seres Therapeutics Corporation Information
Table 28. Seres Therapeutics Description and Business Overview
Table 29. Seres Therapeutics Human Microbiome Product
Table 30. Seres Therapeutics Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Seres Therapeutics Revenue Proportion of Human Microbiome by Product in 2024
Table 32. Seres Therapeutics Revenue Proportion of Human Microbiome by Application in 2024
Table 33. Seres Therapeutics Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 34. Seres Therapeutics Recent Developments
Table 35. Second Genome Corporation Information
Table 36. Second Genome Description and Business Overview
Table 37. Second Genome Human Microbiome Product
Table 38. Second Genome Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Second Genome Revenue Proportion of Human Microbiome by Product in 2024
Table 40. Second Genome Revenue Proportion of Human Microbiome by Application in 2024
Table 41. Second Genome Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 42. Second Genome Recent Developments
Table 43. Rebiotix Corporation Information
Table 44. Rebiotix Description and Business Overview
Table 45. Rebiotix Human Microbiome Product
Table 46. Rebiotix Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Rebiotix Revenue Proportion of Human Microbiome by Product in 2024
Table 48. Rebiotix Revenue Proportion of Human Microbiome by Application in 2024
Table 49. Rebiotix Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 50. Rebiotix Recent Developments
Table 51. ActoGeniX Corporation Information
Table 52. ActoGeniX Description and Business Overview
Table 53. ActoGeniX Human Microbiome Product
Table 54. ActoGeniX Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. ActoGeniX Revenue Proportion of Human Microbiome by Product in 2024
Table 56. ActoGeniX Revenue Proportion of Human Microbiome by Application in 2024
Table 57. ActoGeniX Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 58. ActoGeniX Recent Developments
Table 59. Enterome BioScience Corporation Information
Table 60. Enterome BioScience Description and Business Overview
Table 61. Enterome BioScience Human Microbiome Product
Table 62. Enterome BioScience Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Enterome BioScience Revenue Proportion of Human Microbiome by Product in 2024
Table 64. Enterome BioScience Revenue Proportion of Human Microbiome by Application in 2024
Table 65. Enterome BioScience Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 66. Enterome BioScience Recent Developments
Table 67. AvidBiotics Corporation Information
Table 68. AvidBiotics Description and Business Overview
Table 69. AvidBiotics Human Microbiome Product
Table 70. AvidBiotics Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. AvidBiotics Revenue Proportion of Human Microbiome by Product in 2024
Table 72. AvidBiotics Revenue Proportion of Human Microbiome by Application in 2024
Table 73. AvidBiotics Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 74. AvidBiotics Recent Developments
Table 75. 4D Pharma Research Ltd Corporation Information
Table 76. 4D Pharma Research Ltd Description and Business Overview
Table 77. 4D Pharma Research Ltd Human Microbiome Product
Table 78. 4D Pharma Research Ltd Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. 4D Pharma Research Ltd Revenue Proportion of Human Microbiome by Product in 2024
Table 80. 4D Pharma Research Ltd Revenue Proportion of Human Microbiome by Application in 2024
Table 81. 4D Pharma Research Ltd Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 82. 4D Pharma Research Ltd Recent Developments
Table 83. Enterologics Corporation Information
Table 84. Enterologics Description and Business Overview
Table 85. Enterologics Human Microbiome Product
Table 86. Enterologics Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Enterologics Revenue Proportion of Human Microbiome by Product in 2024
Table 88. Enterologics Revenue Proportion of Human Microbiome by Application in 2024
Table 89. Enterologics Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 90. Enterologics Recent Developments
Table 91. Metabogen Corporation Information
Table 92. Metabogen Description and Business Overview
Table 93. Metabogen Human Microbiome Product
Table 94. Metabogen Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Metabogen Revenue Proportion of Human Microbiome by Product in 2024
Table 96. Metabogen Revenue Proportion of Human Microbiome by Application in 2024
Table 97. Metabogen Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 98. Metabogen Recent Developments
Table 99. Metabiomics Corporation Information
Table 100. Metabiomics Description and Business Overview
Table 101. Metabiomics Human Microbiome Product
Table 102. Metabiomics Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Metabiomics Revenue Proportion of Human Microbiome by Product in 2024
Table 104. Metabiomics Revenue Proportion of Human Microbiome by Application in 2024
Table 105. Metabiomics Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 106. Metabiomics Recent Developments
Table 107. Ritter Pharmaceuticals Corporation Information
Table 108. Ritter Pharmaceuticals Description and Business Overview
Table 109. Ritter Pharmaceuticals Human Microbiome Product
Table 110. Ritter Pharmaceuticals Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Ritter Pharmaceuticals Revenue Proportion of Human Microbiome by Product in 2024
Table 112. Ritter Pharmaceuticals Revenue Proportion of Human Microbiome by Application in 2024
Table 113. Ritter Pharmaceuticals Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 114. Ritter Pharmaceuticals Recent Developments
Table 115. Osel Corporation Information
Table 116. Osel Description and Business Overview
Table 117. Osel Human Microbiome Product
Table 118. Osel Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Osel Revenue Proportion of Human Microbiome by Product in 2024
Table 120. Osel Revenue Proportion of Human Microbiome by Application in 2024
Table 121. Osel Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 122. Osel Recent Developments
Table 123. Symberix Corporation Information
Table 124. Symberix Description and Business Overview
Table 125. Symberix Human Microbiome Product
Table 126. Symberix Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Symberix Revenue Proportion of Human Microbiome by Product in 2024
Table 128. Symberix Revenue Proportion of Human Microbiome by Application in 2024
Table 129. Symberix Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 130. Symberix Recent Developments
Table 131. Miomics Corporation Information
Table 132. Miomics Description and Business Overview
Table 133. Miomics Human Microbiome Product
Table 134. Miomics Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Miomics Revenue Proportion of Human Microbiome by Product in 2024
Table 136. Miomics Revenue Proportion of Human Microbiome by Application in 2024
Table 137. Miomics Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 138. Miomics Recent Developments
Table 139. Symbiotix Biotherapies Corporation Information
Table 140. Symbiotix Biotherapies Description and Business Overview
Table 141. Symbiotix Biotherapies Human Microbiome Product
Table 142. Symbiotix Biotherapies Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Symbiotix Biotherapies Revenue Proportion of Human Microbiome by Product in 2024
Table 144. Symbiotix Biotherapies Revenue Proportion of Human Microbiome by Application in 2024
Table 145. Symbiotix Biotherapies Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 146. Symbiotix Biotherapies Recent Developments
Table 147. MicroBiome Therapeutics LLC Corporation Information
Table 148. MicroBiome Therapeutics LLC Description and Business Overview
Table 149. MicroBiome Therapeutics LLC Human Microbiome Product
Table 150. MicroBiome Therapeutics LLC Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. MicroBiome Therapeutics LLC Revenue Proportion of Human Microbiome by Product in 2024
Table 152. MicroBiome Therapeutics LLC Revenue Proportion of Human Microbiome by Application in 2024
Table 153. MicroBiome Therapeutics LLC Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 154. MicroBiome Therapeutics LLC Recent Developments
Table 155. North America Human Microbiome Revenue by Country (2020-2025) & (US$ Million)
Table 156. North America Human Microbiome Revenue by Country (2026-2031) & (US$ Million)
Table 157. North America Human Microbiome Revenue by Type (2020-2025) & (US$ Million)
Table 158. North America Human Microbiome Revenue by Application (2020-2025) & (US$ Million)
Table 159. Asia-Pacific Human Microbiome Revenue by Region (2020-2025) & (US$ Million)
Table 160. Asia-Pacific Human Microbiome Revenue by Region (2026-2031) & (US$ Million)
Table 161. Asia-Pacific Human Microbiome Revenue by Type (2020-2025) & (US$ Million)
Table 162. Asia-Pacific Human Microbiome Revenue by Application (2020-2025) & (US$ Million)
Table 163. Europe Human Microbiome Revenue by Country (2020-2025) & (US$ Million)
Table 164. Europe Human Microbiome Revenue by Country (2026-2031) & (US$ Million)
Table 165. Europe Human Microbiome Revenue by Type (2020-2025) & (US$ Million)
Table 166. Europe Human Microbiome Revenue by Application (2020-2025) & (US$ Million)
Table 167. Latin America Human Microbiome Revenue by Country (2020-2025) & (US$ Million)
Table 168. Latin America Human Microbiome Revenue by Country (2026-2031) & (US$ Million)
Table 169. Latin America Human Microbiome Revenue by Type (2020-2025) & (US$ Million)
Table 170. Latin America Human Microbiome Revenue by Application (2020-2025) & (US$ Million)
Table 171. Middle East and Africa Human Microbiome Revenue by Country (2020-2025) & (US$ Million)
Table 172. Middle East and Africa Human Microbiome Revenue by Country (2026-2031) & (US$ Million)
Table 173. Middle East and Africa Human Microbiome Revenue by Type (2020-2025) & (US$ Million)
Table 174. Middle East and Africa Human Microbiome Revenue by Application (2020-2025) & (US$ Million)
Table 175. Human Microbiome Key Raw Materials, Industry Status and Trend
Table 176. Human Microbiome Key Raw Materials and Upstream Suppliers
Table 177. Human Microbiome Clients Status and Trend
Table 178. Human Microbiome Typical Clients
Table 179. Human Microbiome Distributors
Table 180. Human Microbiome Market Trends
Table 181. Human Microbiome Market Drivers
Table 182. Human Microbiome Market Challenges
Table 183. Human Microbiome Market Restraints
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Microbiome Product Picture
Figure 2. Global Human Microbiome Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Human Microbiome Revenue Market Share by Type in 2024 & 2031
Figure 4. Gastrointestinal Tract Human Micobiome Product Picture
Figure 5. Urogenital Tract Human Micobiome Product Picture
Figure 6. Others Product Picture
Figure 7. Global Human Microbiome Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Human Microbiome Revenue Market Share by Application in 2024 & 2031
Figure 9. Treatment
Figure 10. Diagnosis
Figure 11. Human Microbiome Report Years Considered
Figure 12. Global Human Microbiome Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Human Microbiome Market Size (2020-2031) & (US$ Million)
Figure 14. Global Human Microbiome Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Human Microbiome Revenue Market Share by Region (2020-2031)
Figure 16. Global Human Microbiome Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Human Microbiome Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Gastrointestinal Tract Human Micobiome of Human Microbiome Revenue Market Share by Application, 2024 VS 2031
Figure 19. Urogenital Tract Human Micobiome of Human Microbiome Revenue Market Share by Application, 2024 VS 2031
Figure 20. Others of Human Microbiome Revenue Market Share by Application, 2024 VS 2031
Figure 21. Human Microbiome Revenue Share by Company (2024)
Figure 22. Human Microbiome Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Gastrointestinal Tract Human Micobiome Revenue Proportion by Company in 2024
Figure 24. Urogenital Tract Human Micobiome Revenue Proportion by Company in 2024
Figure 25. Others Revenue Proportion by Company in 2024
Figure 26. North America Human Microbiome Revenue 2020-2031 (US$ Million)
Figure 27. North America Human Microbiome Revenue Market Share by Type (2020-2025)
Figure 28. North America Human Microbiome Revenue Market Share by Application (2020-2025)
Figure 29. Asia-Pacific Human Microbiome Revenue 2020-2031 (US$ Million)
Figure 30. Asia-Pacific Human Microbiome Revenue Market Share by Region (2020-2031)
Figure 31. Asia-Pacific Human Microbiome Revenue Market Share by Type (2020-2025)
Figure 32. Asia-Pacific Human Microbiome Revenue Market Share by Application (2020-2025)
Figure 33. Europe Human Microbiome Revenue Growth Rate 2020-2031 (US$ Million)
Figure 34. Europe Human Microbiome Revenue Market Share by Country (2020-2031)
Figure 35. Europe Human Microbiome Revenue Market Share by Type (2020-2025)
Figure 36. Europe Human Microbiome Revenue Market Share by Application (2020-2025)
Figure 37. Latin America Human Microbiome Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Latin America Human Microbiome Revenue Market Share by Country (2020-2031)
Figure 39. Latin America Human Microbiome Revenue Market Share by Type (2020-2025)
Figure 40. Latin America Human Microbiome Revenue Market Share by Application (2020-2025)
Figure 41. Middle East and Africa Human Microbiome Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Middle East and Africa Human Microbiome Revenue Market Share by Country (2020-2031)
Figure 43. Middle East and Africa Human Microbiome Revenue Market Share by Type (2020-2025)
Figure 44. Middle East and Africa Human Microbiome Revenue Market Share by Application (2020-2025)
Figure 45. Human Microbiome Supply Chain (Upstream and Downstream Market)
Figure 46. Global Production Market Share of Human Microbiome Raw Materials by Region in 2024
Figure 47. Human Microbiome Distribution Channels
Figure 48. Global Human Microbiome Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 49. Global Human Microbiome Percentage 2020-2031: Online Sales VS Offline Sales
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Table 1. Global Human Microbiome Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Human Microbiome Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Human Microbiome Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Human Microbiome Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Human Microbiome Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Human Microbiome Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Human Microbiome Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Human Microbiome Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Human Microbiome Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Human Microbiome Revenue by Company (2020-2025) & (US$ Million)
Table 11. Human Microbiome Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Human Microbiome Players by Revenue (US$ Million) in 2024
Table 13. Global Human Microbiome Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Human Microbiome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome as of 2024)
Table 15. Global Human Microbiome Companies Headquarters
Table 16. Date of International Companies Enter into Human Microbiome Market
Table 17. Global Human Microbiome Companies Product & Service
Table 18. Global Human Microbiome Mergers & Acquisitions, Expansion Plans
Table 19. Vedanta Corporation Information
Table 20. Vedanta Description and Business Overview
Table 21. Vedanta Human Microbiome Product
Table 22. Vedanta Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Vedanta Revenue Proportion of Human Microbiome by Product in 2024
Table 24. Vedanta Revenue Proportion of Human Microbiome by Application in 2024
Table 25. Vedanta Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 26. Vedanta Recent Developments
Table 27. Seres Therapeutics Corporation Information
Table 28. Seres Therapeutics Description and Business Overview
Table 29. Seres Therapeutics Human Microbiome Product
Table 30. Seres Therapeutics Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Seres Therapeutics Revenue Proportion of Human Microbiome by Product in 2024
Table 32. Seres Therapeutics Revenue Proportion of Human Microbiome by Application in 2024
Table 33. Seres Therapeutics Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 34. Seres Therapeutics Recent Developments
Table 35. Second Genome Corporation Information
Table 36. Second Genome Description and Business Overview
Table 37. Second Genome Human Microbiome Product
Table 38. Second Genome Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Second Genome Revenue Proportion of Human Microbiome by Product in 2024
Table 40. Second Genome Revenue Proportion of Human Microbiome by Application in 2024
Table 41. Second Genome Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 42. Second Genome Recent Developments
Table 43. Rebiotix Corporation Information
Table 44. Rebiotix Description and Business Overview
Table 45. Rebiotix Human Microbiome Product
Table 46. Rebiotix Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Rebiotix Revenue Proportion of Human Microbiome by Product in 2024
Table 48. Rebiotix Revenue Proportion of Human Microbiome by Application in 2024
Table 49. Rebiotix Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 50. Rebiotix Recent Developments
Table 51. ActoGeniX Corporation Information
Table 52. ActoGeniX Description and Business Overview
Table 53. ActoGeniX Human Microbiome Product
Table 54. ActoGeniX Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. ActoGeniX Revenue Proportion of Human Microbiome by Product in 2024
Table 56. ActoGeniX Revenue Proportion of Human Microbiome by Application in 2024
Table 57. ActoGeniX Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 58. ActoGeniX Recent Developments
Table 59. Enterome BioScience Corporation Information
Table 60. Enterome BioScience Description and Business Overview
Table 61. Enterome BioScience Human Microbiome Product
Table 62. Enterome BioScience Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Enterome BioScience Revenue Proportion of Human Microbiome by Product in 2024
Table 64. Enterome BioScience Revenue Proportion of Human Microbiome by Application in 2024
Table 65. Enterome BioScience Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 66. Enterome BioScience Recent Developments
Table 67. AvidBiotics Corporation Information
Table 68. AvidBiotics Description and Business Overview
Table 69. AvidBiotics Human Microbiome Product
Table 70. AvidBiotics Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. AvidBiotics Revenue Proportion of Human Microbiome by Product in 2024
Table 72. AvidBiotics Revenue Proportion of Human Microbiome by Application in 2024
Table 73. AvidBiotics Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 74. AvidBiotics Recent Developments
Table 75. 4D Pharma Research Ltd Corporation Information
Table 76. 4D Pharma Research Ltd Description and Business Overview
Table 77. 4D Pharma Research Ltd Human Microbiome Product
Table 78. 4D Pharma Research Ltd Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. 4D Pharma Research Ltd Revenue Proportion of Human Microbiome by Product in 2024
Table 80. 4D Pharma Research Ltd Revenue Proportion of Human Microbiome by Application in 2024
Table 81. 4D Pharma Research Ltd Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 82. 4D Pharma Research Ltd Recent Developments
Table 83. Enterologics Corporation Information
Table 84. Enterologics Description and Business Overview
Table 85. Enterologics Human Microbiome Product
Table 86. Enterologics Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Enterologics Revenue Proportion of Human Microbiome by Product in 2024
Table 88. Enterologics Revenue Proportion of Human Microbiome by Application in 2024
Table 89. Enterologics Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 90. Enterologics Recent Developments
Table 91. Metabogen Corporation Information
Table 92. Metabogen Description and Business Overview
Table 93. Metabogen Human Microbiome Product
Table 94. Metabogen Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Metabogen Revenue Proportion of Human Microbiome by Product in 2024
Table 96. Metabogen Revenue Proportion of Human Microbiome by Application in 2024
Table 97. Metabogen Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 98. Metabogen Recent Developments
Table 99. Metabiomics Corporation Information
Table 100. Metabiomics Description and Business Overview
Table 101. Metabiomics Human Microbiome Product
Table 102. Metabiomics Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Metabiomics Revenue Proportion of Human Microbiome by Product in 2024
Table 104. Metabiomics Revenue Proportion of Human Microbiome by Application in 2024
Table 105. Metabiomics Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 106. Metabiomics Recent Developments
Table 107. Ritter Pharmaceuticals Corporation Information
Table 108. Ritter Pharmaceuticals Description and Business Overview
Table 109. Ritter Pharmaceuticals Human Microbiome Product
Table 110. Ritter Pharmaceuticals Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Ritter Pharmaceuticals Revenue Proportion of Human Microbiome by Product in 2024
Table 112. Ritter Pharmaceuticals Revenue Proportion of Human Microbiome by Application in 2024
Table 113. Ritter Pharmaceuticals Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 114. Ritter Pharmaceuticals Recent Developments
Table 115. Osel Corporation Information
Table 116. Osel Description and Business Overview
Table 117. Osel Human Microbiome Product
Table 118. Osel Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Osel Revenue Proportion of Human Microbiome by Product in 2024
Table 120. Osel Revenue Proportion of Human Microbiome by Application in 2024
Table 121. Osel Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 122. Osel Recent Developments
Table 123. Symberix Corporation Information
Table 124. Symberix Description and Business Overview
Table 125. Symberix Human Microbiome Product
Table 126. Symberix Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Symberix Revenue Proportion of Human Microbiome by Product in 2024
Table 128. Symberix Revenue Proportion of Human Microbiome by Application in 2024
Table 129. Symberix Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 130. Symberix Recent Developments
Table 131. Miomics Corporation Information
Table 132. Miomics Description and Business Overview
Table 133. Miomics Human Microbiome Product
Table 134. Miomics Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Miomics Revenue Proportion of Human Microbiome by Product in 2024
Table 136. Miomics Revenue Proportion of Human Microbiome by Application in 2024
Table 137. Miomics Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 138. Miomics Recent Developments
Table 139. Symbiotix Biotherapies Corporation Information
Table 140. Symbiotix Biotherapies Description and Business Overview
Table 141. Symbiotix Biotherapies Human Microbiome Product
Table 142. Symbiotix Biotherapies Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Symbiotix Biotherapies Revenue Proportion of Human Microbiome by Product in 2024
Table 144. Symbiotix Biotherapies Revenue Proportion of Human Microbiome by Application in 2024
Table 145. Symbiotix Biotherapies Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 146. Symbiotix Biotherapies Recent Developments
Table 147. MicroBiome Therapeutics LLC Corporation Information
Table 148. MicroBiome Therapeutics LLC Description and Business Overview
Table 149. MicroBiome Therapeutics LLC Human Microbiome Product
Table 150. MicroBiome Therapeutics LLC Human Microbiome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. MicroBiome Therapeutics LLC Revenue Proportion of Human Microbiome by Product in 2024
Table 152. MicroBiome Therapeutics LLC Revenue Proportion of Human Microbiome by Application in 2024
Table 153. MicroBiome Therapeutics LLC Revenue Proportion of Human Microbiome by Geographic Area in 2024
Table 154. MicroBiome Therapeutics LLC Recent Developments
Table 155. North America Human Microbiome Revenue by Country (2020-2025) & (US$ Million)
Table 156. North America Human Microbiome Revenue by Country (2026-2031) & (US$ Million)
Table 157. North America Human Microbiome Revenue by Type (2020-2025) & (US$ Million)
Table 158. North America Human Microbiome Revenue by Application (2020-2025) & (US$ Million)
Table 159. Asia-Pacific Human Microbiome Revenue by Region (2020-2025) & (US$ Million)
Table 160. Asia-Pacific Human Microbiome Revenue by Region (2026-2031) & (US$ Million)
Table 161. Asia-Pacific Human Microbiome Revenue by Type (2020-2025) & (US$ Million)
Table 162. Asia-Pacific Human Microbiome Revenue by Application (2020-2025) & (US$ Million)
Table 163. Europe Human Microbiome Revenue by Country (2020-2025) & (US$ Million)
Table 164. Europe Human Microbiome Revenue by Country (2026-2031) & (US$ Million)
Table 165. Europe Human Microbiome Revenue by Type (2020-2025) & (US$ Million)
Table 166. Europe Human Microbiome Revenue by Application (2020-2025) & (US$ Million)
Table 167. Latin America Human Microbiome Revenue by Country (2020-2025) & (US$ Million)
Table 168. Latin America Human Microbiome Revenue by Country (2026-2031) & (US$ Million)
Table 169. Latin America Human Microbiome Revenue by Type (2020-2025) & (US$ Million)
Table 170. Latin America Human Microbiome Revenue by Application (2020-2025) & (US$ Million)
Table 171. Middle East and Africa Human Microbiome Revenue by Country (2020-2025) & (US$ Million)
Table 172. Middle East and Africa Human Microbiome Revenue by Country (2026-2031) & (US$ Million)
Table 173. Middle East and Africa Human Microbiome Revenue by Type (2020-2025) & (US$ Million)
Table 174. Middle East and Africa Human Microbiome Revenue by Application (2020-2025) & (US$ Million)
Table 175. Human Microbiome Key Raw Materials, Industry Status and Trend
Table 176. Human Microbiome Key Raw Materials and Upstream Suppliers
Table 177. Human Microbiome Clients Status and Trend
Table 178. Human Microbiome Typical Clients
Table 179. Human Microbiome Distributors
Table 180. Human Microbiome Market Trends
Table 181. Human Microbiome Market Drivers
Table 182. Human Microbiome Market Challenges
Table 183. Human Microbiome Market Restraints
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Microbiome Product Picture
Figure 2. Global Human Microbiome Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Human Microbiome Revenue Market Share by Type in 2024 & 2031
Figure 4. Gastrointestinal Tract Human Micobiome Product Picture
Figure 5. Urogenital Tract Human Micobiome Product Picture
Figure 6. Others Product Picture
Figure 7. Global Human Microbiome Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Human Microbiome Revenue Market Share by Application in 2024 & 2031
Figure 9. Treatment
Figure 10. Diagnosis
Figure 11. Human Microbiome Report Years Considered
Figure 12. Global Human Microbiome Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Human Microbiome Market Size (2020-2031) & (US$ Million)
Figure 14. Global Human Microbiome Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Human Microbiome Revenue Market Share by Region (2020-2031)
Figure 16. Global Human Microbiome Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Human Microbiome Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Gastrointestinal Tract Human Micobiome of Human Microbiome Revenue Market Share by Application, 2024 VS 2031
Figure 19. Urogenital Tract Human Micobiome of Human Microbiome Revenue Market Share by Application, 2024 VS 2031
Figure 20. Others of Human Microbiome Revenue Market Share by Application, 2024 VS 2031
Figure 21. Human Microbiome Revenue Share by Company (2024)
Figure 22. Human Microbiome Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Gastrointestinal Tract Human Micobiome Revenue Proportion by Company in 2024
Figure 24. Urogenital Tract Human Micobiome Revenue Proportion by Company in 2024
Figure 25. Others Revenue Proportion by Company in 2024
Figure 26. North America Human Microbiome Revenue 2020-2031 (US$ Million)
Figure 27. North America Human Microbiome Revenue Market Share by Type (2020-2025)
Figure 28. North America Human Microbiome Revenue Market Share by Application (2020-2025)
Figure 29. Asia-Pacific Human Microbiome Revenue 2020-2031 (US$ Million)
Figure 30. Asia-Pacific Human Microbiome Revenue Market Share by Region (2020-2031)
Figure 31. Asia-Pacific Human Microbiome Revenue Market Share by Type (2020-2025)
Figure 32. Asia-Pacific Human Microbiome Revenue Market Share by Application (2020-2025)
Figure 33. Europe Human Microbiome Revenue Growth Rate 2020-2031 (US$ Million)
Figure 34. Europe Human Microbiome Revenue Market Share by Country (2020-2031)
Figure 35. Europe Human Microbiome Revenue Market Share by Type (2020-2025)
Figure 36. Europe Human Microbiome Revenue Market Share by Application (2020-2025)
Figure 37. Latin America Human Microbiome Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Latin America Human Microbiome Revenue Market Share by Country (2020-2031)
Figure 39. Latin America Human Microbiome Revenue Market Share by Type (2020-2025)
Figure 40. Latin America Human Microbiome Revenue Market Share by Application (2020-2025)
Figure 41. Middle East and Africa Human Microbiome Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Middle East and Africa Human Microbiome Revenue Market Share by Country (2020-2031)
Figure 43. Middle East and Africa Human Microbiome Revenue Market Share by Type (2020-2025)
Figure 44. Middle East and Africa Human Microbiome Revenue Market Share by Application (2020-2025)
Figure 45. Human Microbiome Supply Chain (Upstream and Downstream Market)
Figure 46. Global Production Market Share of Human Microbiome Raw Materials by Region in 2024
Figure 47. Human Microbiome Distribution Channels
Figure 48. Global Human Microbiome Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 49. Global Human Microbiome Percentage 2020-2031: Online Sales VS Offline Sales
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232